908 Devices (MASS) Interest & Investment Income (2022 - 2026)
908 Devices' (MASS) quarterly Interest & Investment Income came in at $936000.0 in Q1 2026, up 14.71% year-on-year from $816000.0 in Q1 2025, and down 8.41% on a QoQ basis from $1.0 million in Q4 2025.
908 Devices (MASS) Interest & Investment Income (2022 - 2026) Analysis & Trends
908 Devices (MASS) has 5 years of Interest & Investment Income data on file, last reported at $936000.0 in Q1 2026.
- On a quarterly basis, Interest & Investment Income rose 14.71% year-over-year to $936000.0 in Q1 2026; TTM through Mar 2026 was $4.3 million, a 18.82% increase from a year earlier, with the FY2025 full-year figure at $4.1 million, down 7.97% from the prior year.
- Interest & Investment Income for Q1 2026 stood at $936000.0, down from $1.0 million in the prior quarter.
- Over the last five years, Interest & Investment Income for MASS reached as high as $2.3 million in Q4 2023 and fell as low as $171000.0 in Q1 2022.
- Historically, Interest & Investment Income has averaged $1.1 million across 5 years, with a median of $1.0 million in 2023.
- Across the five-year window, Interest & Investment Income surged 494.74% in 2023 and sank 67.61% in 2024, its largest moves.
- Year by year, Interest & Investment Income stood at $585000.0 in 2022, then soared by 297.44% to $2.3 million in 2023, then sank by 67.61% to $753000.0 in 2024, then soared by 35.72% to $1.0 million in 2025, then slipped by 8.41% to $936000.0 in 2026.
- Per Business Quant data, the three most recent Interest & Investment Income figures were $936000.0 in Q1 2026, $1.0 million in Q4 2025, and $1.1 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn | 106.00 Mn |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn | - |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn | 33.50 Mn |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn | - |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn | - |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn | 40.98 Mn |
| 10 | 908 Devices | 264.17 Mn | 152.43 Mn | 6.88 Mn | 936,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 936,000.00 |
| Dec 31, 2025 | 1.02 Mn |
| Sep 30, 2025 | 1.10 Mn |
| Jun 30, 2025 | 1.20 Mn |
| Mar 31, 2025 | 816,000.00 |
| Dec 31, 2024 | 753,000.00 |
| Sep 30, 2024 | 879,000.00 |
| Jun 30, 2024 | 1.13 Mn |
| Mar 31, 2024 | 1.73 Mn |
| Dec 31, 2023 | 2.33 Mn |
| Sep 30, 2023 | 1.45 Mn |
| Jun 30, 2023 | 1.69 Mn |
| Mar 31, 2023 | 1.02 Mn |
| Dec 31, 2022 | 585,000.00 |
| Sep 30, 2022 | 981,000.00 |
| Jun 30, 2022 | 293,000.00 |
| Mar 31, 2022 | 171,000.00 |